| Global strategy for asthma management and prevention: GINA executive summary ED Bateman, SS Hurd, PJ Barnes, J Bousquet, JM Drazen, M FitzGerald, ... European Respiratory Journal 31 (1), 143-178, 2008 | 4162 | 2008 |
| Clinical trial registration: a statement from the International Committee of Medical Journal Editors C De Angelis, JM Drazen, FA Frizelle, C Haug, J Hoey, R Horton, S Kotzin, ... The Lancet 364 (9438), 911-912, 2004 | 2224 | 2004 |
| Statistics in medicine—reporting of subgroup analyses in clinical trials R Wang, SW Lagakos, JH Ware, DJ Hunter, JM Drazen New England Journal of Medicine 357 (21), 2189-2194, 2007 | 1376 | 2007 |
| The biology of nitrogen oxides in the airways. B Gaston, JM Drazen, J Loscalzo, JS Stamler American journal of respiratory and critical care medicine 149 (2), 538-551, 1994 | 1173 | 1994 |
| Treatment of asthma with drugs modifying the leukotriene pathway JM Drazen, E Israel, PM O'Byrne New England Journal of Medicine 340 (3), 197-206, 1999 | 1138 | 1999 |
| Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization L Kobzik, DS Bredt, CJ Lowenstein, J Drazen, B Gaston, D Sugarbaker, ... American journal of respiratory cell and molecular biology 9, 371-371, 1993 | 979 | 1993 |
| Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma J Bousquet, E Mantzouranis, AA Cruz, N Aït-Khaled, CE Baena-Cagnani, ... Journal of Allergy and Clinical Immunology 126 (5), 926-938, 2010 | 967 | 2010 |
| A summary of the new GINA strategy: a roadmap to asthma control HK Reddel, ED Bateman, A Becker, LP Boulet, AA Cruz, JM Drazen, ... European Respiratory Journal 46 (3), 622-639, 2015 | 943 | 2015 |
| Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet S Finotto, MF Neurath, JN Glickman, S Qin, HA Lehr, FHY Green, ... Science 295 (5553), 336-338, 2002 | 902 | 2002 |
| Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. JM Drazen, KF Austen, RA Lewis, DA Clark, G Goto, A Marfat, EJ Corey Proceedings of the National Academy of Sciences 77 (7), 4354-4358, 1980 | 860 | 1980 |
| Sponsorship, authorship, and accountability F Davidoff, CD DeAngelis, JM Drazen, J Hoey, L Højgaard, R Horton, ... The Lancet 358 (9285), 854-856, 2001 | 847 | 2001 |
| Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. B Gaston, J Reilly, JM Drazen, J Fackler, P Ramdev, D Arnelle, ... Proceedings of the National Academy of Sciences 90 (23), 10957-10961, 1993 | 786 | 1993 |
| Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. K Asano, CB Chee, B Gaston, CM Lilly, C Gerard, JM Drazen, JS Stamler Proceedings of the National Academy of Sciences 91 (21), 10089-10093, 1994 | 736 | 1994 |
| Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment JM Drazen, CN Yandava, L Dubé, N Szczerback, R Hippensteel, A Pillari, ... Nature genetics 22 (2), 168-170, 1999 | 723 | 1999 |
| Significant variability in response to inhaled corticosteroids for persistent asthma SJ Szefler, RJ Martin, TS King, HA Boushey, RM Cherniack, VM Chinchilli, ... Journal of Allergy and Clinical Immunology 109 (3), 410-418, 2002 | 710 | 2002 |
| Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial E Israel, VM Chinchilli, JG Ford, HA Boushey, R Cherniack, TJ Craig, ... The Lancet 364 (9444), 1505-1512, 2004 | 707 | 2004 |
| The Effect of Polymorphisms of the β2-Adrenergic Receptor on the Response to Regular Use of Albuterol in Asthma E Israel, JM Drazen, SB Liggett, HA Boushey, RM Cherniack, ... American journal of respiratory and critical care medicine 162 (1), 75-80, 2000 | 671 | 2000 |
| Evidence for health decision making—beyond randomized, controlled trials TR Frieden New England Journal of Medicine 377 (5), 465-475, 2017 | 654 | 2017 |
| The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo N Chiang, CN Serhan, SE Dahlén, JM Drazen, DWP Hay, GE Rovati, ... Pharmacological reviews 58 (3), 463-487, 2006 | 593 | 2006 |
| Slow reacting substances of anaphylaxis: identification of leukotrienes C-1 and D from human and rat sources RA Lewis, KF Austen, JM Drazen, DA Clark, A Marfat, EJ Corey Proceedings of the National Academy of Sciences 77 (6), 3710-3714, 1980 | 579 | 1980 |
